Showing results (1271-1280 of 1,490) with videos related to

Sort By:
Pageof 149
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancerFotios Loupakis, Luca Pollina, Irene Stasi, et al.
British Journal of Cancer|July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerF Loupakis, A Ruzzo, C Cremolini, et al.
BMC Cancer|June 15, 2011
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancerFotios Loupakis, Annamaria Ruzzo, Lisa Salvatore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 childrenG P Tonini, L Boni, A Pession, et al.
Biological Psychiatry|January 14, 2026
Atypical depression is associated with a distinct clinical, neurobiological, treatment response and polygenic risk profileMirim Shin, Jacob J Crouse, Tian Lin, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 1, 2021
Occurrence of genes associated with virulence in Escherichia coli isolates from chicken carcasses at different stages of processing at a slaughterhouseJoão Juliano Pinheiro, Luiz Eduardo de Souza Gazal, Gabriella Oliveira de Araujo, et al.
Plos One|May 12, 2011
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsDaniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
Clinical Sarcoma Research|April 19, 2013
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment optionsBruno Vincenzi, Anna Maria Frezza, Gaia Schiavon, et al.
Integrative Cancer Therapies|February 4, 2020
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of LiteratureLidia Gatto, Massimo Del Gaudio, Matteo Ravaioli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trialsC Cremolini, F Loupakis, G Masi, et al.
Pageof 149